Bacteremia DMI Kit

Evidence for Targeted Therapy

Analysis of positive blood cultures for the identification of the most relevant bacteremia-causing bacteria

Bacteremia is one of the most frequent hospital-acquired infections (HAIs). Resultant sepsis and septic shock mandate early intervention because survival rates decrease dramatically by every hour of delayed antibiotic treatment. Initial therapy relies on broad-band antibiotics until the pathogenic microorganisms can be identified. But broad-band antibiotics are often ineffective and contribute to surging bacterial resistance.

Fast pathogen identification, together with information about patient history and resistance incidence, is key for rapid and appropriate adaption of antimicrobial therapy for best patient outcomes – as well as to restrict accelerating antibiotic resistance.

Images

' target='_blank'>Your cookie settings prevent this video from being displayed.

Fast ID of pathogens

' target='_blank'>Your cookie settings prevent this video from being displayed.
Need Help?

Order Information

* MetaSystems products are used in many countries worldwide. Depending on the regulations of the respective country or region, some products may not be used for clinical diagnostic use. In Europe MetaSystems products are CE labelled in-vitro diagnostics (IVD) devices. In the USA all MetaSystems products except the Ikaros karyotyping systems are intended to be used for research or inspection only.

Downloads

Manufacturer Certificate

or search all certificates
' target='_blank'>Your cookie settings prevent this video from being displayed.